Literature DB >> 16467045

Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.

S Yardim-Akaydin1, A Sepici, Y Ozkan, B Simşek, V Sepici.   

Abstract

The increased production of reactive oxygen species (ROS) from activated neutrophils in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS) may result in increased oxidative stress. Uric acid can react rapidly with neutrophil-derived ROS to form allantoin. The purpose of the study was to evaluate the serum levels of allantoin as a new marker of oxidative stress in BD compared with malondialdehyde (MDA) levels as a well-known marker. Blood samples were obtained from 23 BD patients, 22 RAS patients as positive controls, and 21 healthy controls. When compared to the healthy controls, we found higher allantoin and MDA levels in the BD patients and higher MDA levels in the RAS patients. Serum ascorbic acid levels in the BD patients were significantly lower than in the controls. Increased allantoin and MDA levels suggest the possible involvement of free radicals in BD. As allantoin is only a product of uric acid oxidation by reactive oxygen and nitrogen species, it may also be used as a marker of oxidative stress in BD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467045     DOI: 10.1080/03009740510026878

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Oxidative stress and recurrent aphthous stomatitis.

Authors:  Jose Bagan; Guillermo Saez; Carmen Tormos; Carmen Gavalda; Jose M Sanchis; Leticia Bagan; Crispian Scully
Journal:  Clin Oral Investig       Date:  2014-01-10       Impact factor: 3.573

2.  Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Adviye A Tolun; Haoyue Zhang; Dora Il'yasova; Judit Sztáray; Sarah P Young; David S Millington
Journal:  Anal Biochem       Date:  2010-03-31       Impact factor: 3.365

3.  Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.

Authors:  Xia Liu; Wei Wang; Hua-Li Chen; Hai-Yan Zhang; Nai-Xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2019-05-14       Impact factor: 6.150

4.  The association between total antioxidant status and oxidative stress in Behçet's disease.

Authors:  Aylin Sepici-Dinçel; Yeşim Ozkan; Sevgi Yardim-Akaydin; Gülçin Kaymak-Karataş; Meltem Onder; Bolkan Simşek
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

5.  Organization of the Mammalian Metabolome according to Organ Function, Lineage Specialization, and Longevity.

Authors:  Siming Ma; Sun Hee Yim; Sang-Goo Lee; Eun Bae Kim; Sang-Rae Lee; Kyu-Tae Chang; Rochelle Buffenstein; Kaitlyn N Lewis; Thomas J Park; Richard A Miller; Clary B Clish; Vadim N Gladyshev
Journal:  Cell Metab       Date:  2015-08-04       Impact factor: 27.287

6.  Evaluation of Pre-Treatment and Post-Treatment S100B, Oxidant and Antioxidant Capacity in Children with Diabetic Ketoacidosis.

Authors:  Cemil Kaya; Ali Ataş; Nurten Aksoy; Esra Celen Kaya; Mahmut Abuhandan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

7.  Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model.

Authors:  Roel Van Assche; Liesbet Temmerman; Daniel A Dias; Berin Boughton; Kurt Boonen; Bart P Braeckman; Liliane Schoofs; Ute Roessner
Journal:  Metabolomics       Date:  2014-07-30       Impact factor: 4.290

8.  Metabolomic profiling to characterize acute intestinal ischemia/reperfusion injury.

Authors:  Rachel G Khadaroo; Thomas A Churchill; Victor Tso; Karen L Madsen; Chris Lukowski; Saad Y Salim
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

9.  Effects of vitamin D on apoptosis and betatrophin in the kidney tissue of experimental diabetic rats.

Authors:  Selçuk Demircan; Erhan Onalan; Tuncay Kuloğlu; Süleyman Aydın; Mehmet Hanifi Yalçın; Nevzat Gözel; Emir Dönder
Journal:  Acta Biomed       Date:  2020-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.